Tafero 25Mg Tablets

2000 INR/Bottle

Get a Price/Quote

Product Details:

Drug Type Health Supplements
Ingredients Tenofovir Alafenamide Tablets
Physical Form Tablets
Dosage As Directed by the Physician
Dosage Guidelines Warning: keep out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.
Suitable For Suitable For All
Storage Instructions Store below 30C
Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Price And Quantity

Price 2000 INR/Bottle
Minimum Order Quantity 2 Bottle

Product Specifications

Physical Form Tablets
Drug Type Health Supplements
Storage Instructions Store below 30C
Ingredients Tenofovir Alafenamide Tablets
Suitable For Suitable For All
Dosage As Directed by the Physician
Dosage Guidelines Warning: keep out of the reach and sight of children and away from pets, never share your medicines with others, and use this medication only for the indication prescribed. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects.

Trade Information

Payment Terms Cash on Delivery (COD) Cash Advance (CA) Cash in Advance (CID) Cheque Telegraphic Transfer (T/T)
Supply Ability 20 Bottle Per Day
Delivery Time 7 Days
Main Export Market(s) Asia Australia Central America North America South America Eastern Europe Western Europe Middle East Africa
Main Domestic Market All India

Product Description

Tafero medicine is manufactured by Hetero labs.Tafero medicine contains generic salt content Tenofovir alafenamide fumerate.Tafero is available in tablets form.

Tenofovir alafenamide (trade name Vemlidy) is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir. It was developed by Gilead Sciences for use in the treatment of HIV infection and chronic hepatitis B, and is applied in the form of tenofovir alafenamide fumarate (TAF). Closely related to the commonly used reverse-transcriptase inhibitor tenofovir disoproxil fumarate (TDF), TAF has greater antiviral activity and better distribution into lymphoid tissues than that agent. Gilead was awarded FDA approval in November 2016 for the drug Vemlidy.